CN1060083C - Lung tuberculosis treating bolus and its prepn - Google Patents
Lung tuberculosis treating bolus and its prepn Download PDFInfo
- Publication number
- CN1060083C CN1060083C CN97115216A CN97115216A CN1060083C CN 1060083 C CN1060083 C CN 1060083C CN 97115216 A CN97115216 A CN 97115216A CN 97115216 A CN97115216 A CN 97115216A CN 1060083 C CN1060083 C CN 1060083C
- Authority
- CN
- China
- Prior art keywords
- grams
- pulmonary tuberculosis
- radix
- pill
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000008128 pulmonary tuberculosis Diseases 0.000 title claims abstract description 29
- 239000006187 pill Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- -1 amido sodium salicylate Chemical compound 0.000 claims description 3
- 229960003350 isoniazid Drugs 0.000 claims description 3
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims description 3
- 229960001225 rifampicin Drugs 0.000 claims description 3
- 229960004025 sodium salicylate Drugs 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000010271 massa medicata fermentata Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000007689 inspection Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 241000490229 Eucephalus Species 0.000 abstract 1
- 241001547127 Fritillaria cirrhosa Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 description 11
- 230000003419 expectorant effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010036790 Productive cough Diseases 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 206010060891 General symptom Diseases 0.000 description 6
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 208000024794 sputum Diseases 0.000 description 5
- 210000003802 sputum Anatomy 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 208000004224 Opium Dependence Diseases 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 201000010098 pleural tuberculosis Diseases 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a lung tuberculosis pill and a preparation method thereof, and the formula is as follows: 9-10 g of fructus amomi, 25-30 g of ephedra, 20-40 g of aster, 10-15 g of liquorice, 5-20 g of angelica, 20 g of astragalus, 20-30 g of loquat leaf, 15-20 g of honeysuckle, 15-20 g of medicinal fermented mass, 18-20 g of hawthorn, 10 g of fritillaria cirrhosa, 15-20 g of bletilla, 15 g of radix stemonae, 18-20 g of radix ophiopogonis, 25-30 g of semen brassicae, 20 g of schisandra chinensis, 50-60 tablets (0.5 g/tablet) of ramification, PS and/or lifloxapine, and prepared into 120 pills with 9 g of each pill. Clinical data show that the cure rate of the pulmonary tuberculosis pill of the invention is 86.78 percent, the total effective rate is 95.8 percent, the pulmonary tuberculosis pill does not relapse after healing, has no toxic or side effect after long-term administration, has no drug resistance, and has obvious effect on different types of patients and pulmonary tuberculosis.
Description
The present invention relates to a kind of phthisical Chinese herbal pill and preparation method thereof of specially controlling.
The western medicine pulmonary tuberculosis adopts isoniazid usually, to amido sodium salicylate and/or rifampicin, take the back toxic side effect for a long time, can develop immunity to drugs more easily recurrence of back.
The objective of the invention is to develop a kind of to the pulmonary tuberculosis cure rate is high, that do not recur after more, toxic and side effects is little and do not have Traditional Chinese medicine bolus for treating pulmonary tuberculosis of Drug resistance and preparation method thereof.
Traditional Chinese medicine bolus for treating pulmonary tuberculosis of the present invention is a kind of compositions, and material medicine is composed as follows:
Fructus Amomi 9-10 grams, Herba Ephedrae 25-30 grams, Radix Asteris 20-40 grams, Radix Glycyrrhizae 10-15 grams, Radix Angelicae Sinensis 15-20 grams, the Radix Astragali 20 grams, Folium Eriobotryae 20-30 grams, Flos Lonicerae 15-20 grams, Massa Medicata Fermentata 15-20 grams, Fructus Crataegi 18-20 grams, Bulbus Fritillariae Cirrhosae 10 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20 grams, the Radix Stemonae 15 grams, restrain Radix Ophiopogonis 18-20, Semen Sinapis Albae 25-30 grams, Fructus Schisandrae Chinensis 20 grams, isoniazid, to amido sodium salicylate and/or 50-60 of rifampicin (0.5 gram/sheet), make 120 balls altogether, every ball about 9 the gram.
Also can add following material medicine in the above-mentioned composition:
Radix Platycodonis 10-15 gram Radix Salviae Miltiorrhizaes 10-20 gram Cortex Lycii 10-15 grams
The preparation method of Traditional Chinese medicine bolus for treating pulmonary tuberculosis of the present invention is:
1. pick up the interior silt particle of clean medicine, foreign material etc., remove powder such as earth and foreign material with the scalping sieve;
2. by the coarse pulverization of said ratio elder generation, regrind into fine powder, stir;
3. use the ultraviolet radiation disinfection fine powder;
4. with the Mel heating and filtering, reuse copper pot decocts, and removes clean wax foam, endures to dropping liquid Cheng Zhu;
5. above-mentioned medicated powder and Mel are stirred, the garden of making about nine grams of every ball is spherical, after paper that the reuse disinfection by ultraviolet light is crossed and the wax shell packing, seals with wax.
Clinical data shows that Traditional Chinese medicine bolus for treating pulmonary tuberculosis is treated phthisical cure rate up to 86.78%, and total effective rate is 95.87%.Concrete condition is as follows:
Patient: male 1429 people, women 1406 people, totally 2835 people, age: 94 examples below 10 years old, 11-20 years old 235 example, 21-30 years old 1265 example, 31-40 years old 68 example, 41-50 years old 235 example, 51-60 years old 209 example, 116 examples more than 60 years old; The course of disease: 1699 examples of person below 6 months had 1775 examples in 6-12 months, 561 examples more than 12 months; Typing: primary pulmonary tuberculosis 680 examples, blood group are sent out type 420 examples, infiltrative type 1429 examples, chronic fiber air-conditioning-type 235 examples, tuberculous pleuritis 71 examples.
Instructions about how to take medicine: every day son, noon, the fourth of the twelve Earthly Branches, respectively obey 1 ball the 4 o'clock tenth of the twelve Earthly Branches, children's is cut down according to the circumstance.
The course of treatment: 4-6 months
The treatment standard:
1. cure: expectorant bacterium negative continuously (or cloudy continuously commentaries on classics), pathological changes absorb or do not have an activeness; The cavity
Closure all reaches above person half a year; If any the cavity, then need the cloudy continuously commentaries on classics of expectorant bacterium 1 year
Above person; General Symptoms disappears.
2. produce effects: General Symptoms obviously improves; The expectorant bacterium is cloudy continuously to be changeed, and pathological changes obviously absorbs or absorbs;
The cavity is closed or dwindle, and all reaches person more than three months.
3. effective: General Symptoms improves; Sputum conversion, pathological changes obviously absorb, absorb or do not have a change,
The cavity is closed, dwindles or does not have change, all reaches person more than month; The expectorant bacterium is continuous
Feminine gender, pathological changes absorbs, and the cavity dwindles, and all reaches person more than month.
4. invalid: General Symptoms, expectorant bacterium, X be red all not to have change.
Therapeutic outcome:
This is organized among the 2835 routine patients, and clinical cure 2461 examples account for 86.78%; Produce effects 209 examples account for 7.44%; Effective 48 examples account for 1.65%; Invalid 117 examples account for 4.13%, and total effective rate reaches 95.87%.2835 routine pulmonary tuberculosis case curative effect statistics
Cure | Produce effects | Effectively | Invalid | Add up to |
2461 86.78 | 209 7.44 | 48 1.65 | 117 4.13 | 2835 100% |
Case one:
Open * *, man, 29 years old, the willow gulf miner people of Fenxi mineral bureau.Suffered from chronic fibro cavernous pulmonary tuberculosis 7 years, integrative therapy, the time heavy when light.When go to a doctor in October, 85, see that body is thin and weak, pale complexion, low grade fever, night sweat, tachypnea uncomfortable in chest, it is unable to cough, and abundant expectoration is rare clearly, sputum mixed with blood, spitting of blood is more than sometimes, indigestion and loss of appetite abdominal distention.Pale tongue, fat tender, there is indentation on the limit, and tongue is greasy in vain, deep,thready and forceless pulse.
Dialectical: deficiency of YIN leading to consumption of QI, the lung spleen causes impairment of purifying function of the lung with sick, and dysfunction of the spleen in transportation is the pathological changes in pulmonary tuberculosis later stage.Insufficiency of lung-QI, so cough is unable, shortness of breath and low voice; Failure of qi transforming fluid forms the expectorant disease, sees that then expectorant is clear rare and amount is many; The deficiency of vital energy can not Gu Wei, thus fever of the body, spontaneous perspiration.It is one QI failing to control blood then, the witness of the dysfunction of the spleen.
Diagnosis: pulmonary tuberculosis (deficiency of both QI and YIN)
Method of treatment: nourishing YIN and moistening the lung, replenishing QI to invigorate the spleen
Side's medicine: Traditional Chinese medicine bolus for treating pulmonary tuberculosis
Instructions about how to take medicine: every day son, noon, the fourth of the twelve Earthly Branches, respectively obey 1 ball the 4 o'clock tenth of the twelve Earthly Branches, eliminating cold for resuscitation water send down, period in a medicine is avoided clothes rareripe, living Bulbus Allii, tobacco and wine.
Nurse: note lying up, regulate nutrition.
Auxiliary examination: hemoglobin 8.5 grams, erythrocyte sedimentation rate 52mm/H, expectorant is coated with (+); X line film making is seen: the chronic fibro cavernous pulmonary tuberculosis progressive stage.
Therapeutic outcome: the back clothes Traditional Chinese medicine bolus for treating pulmonary tuberculosis of being admitted to hospital, instructions about how to take medicine are the same.Through treatment in two months, diet increased, and spirit takes a turn for the better, and spitting of blood stops, cough once in a while, and amount of expectoration reduces.X line perspective sees that focus absorbs to some extent.After four months, General Symptoms obviously improves, sputum conversion.Hospitalization is six months altogether, and General Symptoms disappears, and the cavity is closed, continuous four months cloudy commentaries on classics of expectorant bacterium.Recurrence is not followed up a case by regular visits in the coal mining of going into the well in May, 97 so far.
Case two:
The king * *, man, 33 years old, the cadre of Lingshi County county Party committee.Suffer from infiltrative pulmonary tuberculosis a year and a half, cough, hemoptysis, chest pain in the aggravation February of losing heart, is gone to a doctor in February, 82.Disease is seen emaciated physique, darkish complexion, and cough is violent, sputum mixed with blood, hoarseness, chest pain and shortness of breath, fever and sweating, poor appetite, purplish tongue, thready and hesitant pulse.
Dialectical: sick blood stasis for a long time, the respectful function of falling is lost in the lung pulse retardance, the sputum mixed with blood so cough is violent, congestion is not all right, and nutrient QI being deficient is defended heat, fever and sweating then, hypofunction of YANG QI in chest, chest pain and losing heart then, purplish tongue, thready and hesitant pulse is blood vessels levying of becoming silted up and hinder.
Diagnosis: pulmonary tuberculosis (QI and blood stasis type)
The rule of treatment: moistening the lung and resolving phlegm, the silt collateral dredging of dispelling.
Side's medicine: Traditional Chinese medicine bolus for treating pulmonary tuberculosis
Instructions about how to take medicine: from 6 o'clock mornings, every six hours clothes one balls, eliminating cold for resuscitation water sent down.Medication period is avoided clothes rareripe, living Bulbus Allii, the wine of banning on opium-smoking and the opium trade for a long time.
Nurse: have additional nutrients, lie up
Auxiliary examination: hemoglobin 8 gram %, erythrocyte sedimentation rate 48mm/H, light be coated with (+), X-ray film finding: right lung infiltrative pulmonary tuberculosis (progressive stage).
Therapeutic outcome: treated one month after annotating institute, the cough chest pain obviously alleviates, and expectorant is coated with cloudy the commentaries on classics, and all diseases disappear after March, and through laboratory examination, hemoglobin 13 restrains %, and erythrocyte sedimentation rate 2mm/H, expectorant are coated with continuous cloudy the commentaries on classics.The X sheet shows: right lung is dispersed in most point shape scleroma calcification shadows, and two lung marking are more coarse, follow up a case by regular visits to so far not recurrence in February, 92.
Clinical data shows that the effect of Traditional Chinese medicine bolus for treating pulmonary tuberculosis of the present invention is apparent and easy:
1. cure rate is up to 86.78%, total effective rate 95.87%.
2. follow up a case by regular visits to after more and show, do not recur after more.
3. the patient is followed up a case by regular visits to and show that Traditional Chinese medicine bolus for treating pulmonary tuberculosis has no side effect, no Drug resistance.
4. to the patient of all ages and classes, dissimilar pulmonary tuberculosis all has produce effects.
Claims (2)
1. pulmonary tuberculosis pill, it is characterized in that material medicine is composed as follows: Fructus Amomi 9-10 grams, Herba Ephedrae 25-30 grams, Radix Asteris 20-40 grams, Radix Glycyrrhizae 10-15 grams, Radix Angelicae Sinensis 15-20 grams, the Radix Astragali 20 grams, Folium Eriobotryae 20-30 grams, Flos Lonicerae 15-20 grams, Massa Medicata Fermentata 15-20 grams, Fructus Crataegi 18-20 grams, Bulbus Fritillariae Cirrhosae 10 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20 grams, the Radix Stemonae 15 grams, restrain Radix Ophiopogonis 18-20, Semen Sinapis Albae 25-30 gram, Fructus Schisandrae Chinensis 20 grams, isoniazid, to 60-60 of the rifampicin of amido sodium salicylate and/or every 20.5 gram.
2. the method for making of Traditional Chinese medicine bolus for treating pulmonary tuberculosis as claimed in claim 1 is characterized in that:
(1) silt particle in the clean medicine of inspection, foreign material etc. remove powder such as earth and foreign material with the scalping sieve;
(2) by the coarse pulverization of said ratio elder generation, regrind into fine powder, stir;
(3) use the ultraviolet radiation disinfection fine powder;
(4) with the Mel heating and filtering, reuse copper pot decocts, and removes clean wax foam, endures to dropping liquid Cheng Zhu;
(5) above-mentioned medicated powder and Mel are stirred, the garden of making about nine grams of every ball is spherical, after paper that the reuse disinfection by ultraviolet light is crossed and the wax shell packing, seals with wax.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97115216A CN1060083C (en) | 1997-08-19 | 1997-08-19 | Lung tuberculosis treating bolus and its prepn |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97115216A CN1060083C (en) | 1997-08-19 | 1997-08-19 | Lung tuberculosis treating bolus and its prepn |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1208628A CN1208628A (en) | 1999-02-24 |
CN1060083C true CN1060083C (en) | 2001-01-03 |
Family
ID=5173213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97115216A Expired - Fee Related CN1060083C (en) | 1997-08-19 | 1997-08-19 | Lung tuberculosis treating bolus and its prepn |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1060083C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446429B (en) * | 2013-08-28 | 2015-03-25 | 贵州鸿德中药开发有限公司 | Medicine for treating phthisis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1106290A (en) * | 1994-02-02 | 1995-08-09 | 刘玉正 | Chinese medicine "Jiehekang" for treatment of tuberculosis and its prepn. |
CN1138404A (en) * | 1994-01-04 | 1996-12-18 | 诺基亚电信公司 | A mobile communication system and a base tation in a mobile communication system |
-
1997
- 1997-08-19 CN CN97115216A patent/CN1060083C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1138404A (en) * | 1994-01-04 | 1996-12-18 | 诺基亚电信公司 | A mobile communication system and a base tation in a mobile communication system |
CN1106290A (en) * | 1994-02-02 | 1995-08-09 | 刘玉正 | Chinese medicine "Jiehekang" for treatment of tuberculosis and its prepn. |
Non-Patent Citations (3)
Title |
---|
中医杂志1993,34(8) 1993.8.31 王学瑞,中药治疗药物流产后出血的疗效观察 * |
安徽中医学院学报1994,13(1) 1994.1.31 张翠萍,固冲清宫汤治疗药物流产后出血过多48例 * |
安徽中医学院学报1994,13(1) 1994.1.31 张翠萍,固冲清宫汤治疗药物流产后出血过多48例;中医杂志1993,34(8) 1993.8.31 王学瑞,中药治疗药物流产后出血的疗效观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1208628A (en) | 1999-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1562151A (en) | Medicinal formulation for treating upper respiratory track infection and its design method | |
CN101342317A (en) | Medicament composition for treating tuberculosis and preparation method thereof | |
CN101822806A (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
CN1486740A (en) | Chinese medicine composition for treating cancer | |
CN103520395A (en) | Traditional Chinese medicine composition for treating lung cancer | |
CN103041277A (en) | Traditional Chinese medicine for treating peptic ulcer | |
CN1301743C (en) | Chinese medicinal formula for treating chronic bronchitis | |
CN101361789B (en) | Traditional Chinese medicine formulation for treating and preventing lung impairment after tumor controlling radiotherapy | |
CN1060083C (en) | Lung tuberculosis treating bolus and its prepn | |
CN101732467B (en) | Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy | |
CN103394002B (en) | Medicinal composition for treating cutaneous pruritus as well as preparation method and application thereof | |
CN102614474A (en) | Traditional Chinese medicine for treating coronary heart disease and preparation method thereof | |
CN1150927C (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
CN101623387B (en) | Pill for treating traumatic injury, new and old fracture and lumbar muscle strain | |
CN1730093A (en) | Chinese traditional medicine preparation for treating cancer and application thereof | |
CN106822733B (en) | Ointment for treating precancerous lesion of chronic atrophic gastritis and preparation method thereof | |
CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
CN105982906A (en) | Application of 20(R)-ginsenoside Rg3 in preparing medicines or health products capable of alleviating or/and treating rheumatoid diseases and medicines | |
CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
CN100333777C (en) | Medicine for improving enterogastric function after radiation chemiotherapy | |
CN1237435A (en) | Oral medicine for treating phlegm-heat cough | |
CN1613466A (en) | Paste for treating cancers | |
CN101780155A (en) | Application of medicament containing liquorice and radix paeoniae alba in preparing synergistic medicament for treating diabetes | |
CN1314409C (en) | Medicine for inhibiting and eliminating cancer | |
CN106266334A (en) | A kind of Chinese medicine composition treating fat concurrent hyperlipemia and acupuncture and drugs application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1051572 Country of ref document: HK |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |